Human Genome Epidemiology Literature Finder
Records 1 - 3 (of 3 Records) |
Query Trace: Leukocytosis and IDH1[original query] |
---|
Durable Remissions with Ivosidenib in IDH1-Mutated Relapsed or Refractory AML. The New England journal of medicine 2018 6 378 (25): 2386-2398. DiNardo Courtney D, Stein Eytan M, de Botton Stéphane, Roboz Gail J, Altman Jessica K, Mims Alice S, Swords Ronan, Collins Robert H, Mannis Gabriel N, Pollyea Daniel A, Donnellan Will, Fathi Amir T, Pigneux Arnaud, Erba Harry P, Prince Gabrielle T, Stein Anthony S, Uy Geoffrey L, Foran James M, Traer Elie, Stuart Robert K, Arellano Martha L, Slack James L, Sekeres Mikkael A, Willekens Christophe, Choe Sung, Wang Hongfang, Zhang Vickie, Yen Katharine E, Kapsalis Stephanie M, Yang Hua, Dai David, Fan Bin, Goldwasser Meredith, Liu Hua, Agresta Sam, Wu Bin, Attar Eyal C, Tallman Martin S, Stone Richard M, Kantarjian Hagop |
Co-mutation pattern, clonal hierarchy, and clone size concur to determine disease phenotype of SRSF2-mutated neoplasms. Leukemia 2020 12 35 (8): 2371-2381. Todisco Gabriele, Creignou Maria, Gallì Anna, Guglielmelli Paola, Rumi Elisa, Roncador Marco, Rizzo Ettore, Nannya Yasuhito, Pietra Daniela, Elena Chiara, Bono Elisa, Molteni Elisabetta, Rosti Vittorio, Catricalá Silvia, Sarchi Martina, Dimitriou Marios, Ungerstedt Johanna, Vannucchi Alessandro Maria, Hellström-Lindberg Eva, Ogawa Seishi, Cazzola Mario, Malcovati Lu |
Effect of DNMT3A variant allele frequency and double mutation on clinicopathologic features of patients with de novo AML. Blood advances 2021 Jun 5 (11): 2539-2549. Narayanan Damodaran, Pozdnyakova Olga, Hasserjian Robert P, Patel Sanjay S, Weinberg Olga |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: